149 related articles for article (PubMed ID: 37750940)
1. Spectral CT imaging versus conventional CT post-processing technique in differentiating malignant and benign renal tumors.
Zhu Q; Sun J; Zhu W; Chen W; Ye J
Br J Radiol; 2023 Nov; 96(1151):20230147. PubMed ID: 37750940
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of conventional ROI-based and volumetric histogram analysis derived from CT enhancement in differentiating malignant and benign renal tumors.
Zhu Q; Zou J; Ye J; Zhu W; Wu J; Chen W
Br J Radiol; 2022 Jul; 95(1135):20210801. PubMed ID: 35333594
[TBL] [Abstract][Full Text] [Related]
3. Differentiating between malignant and benign renal tumors: do IVIM and diffusion kurtosis imaging perform better than DWI?
Ding Y; Tan Q; Mao W; Dai C; Hu X; Hou J; Zeng M; Zhou J
Eur Radiol; 2019 Dec; 29(12):6930-6939. PubMed ID: 31161315
[TBL] [Abstract][Full Text] [Related]
4. CT differentiation of the oncocytoma and renal cell carcinoma based on peripheral tumor parenchyma and central hypodense area characterisation.
Qu J; Zhang Q; Song X; Jiang H; Ma H; Li W; Wang X
BMC Med Imaging; 2023 Jan; 23(1):16. PubMed ID: 36707788
[TBL] [Abstract][Full Text] [Related]
5. [Role of multiphasic multidetector CT imaging in differential diagnosis of small renal cell carcinoma].
Zhang Y; Gao W; Zhao B; Zhang X
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):850-4. PubMed ID: 26887517
[TBL] [Abstract][Full Text] [Related]
6. Use of specific contrast-enhanced CT regions of interest to differentiate renal oncocytomas from small clear cell and chromophobe renal cell carcinomas.
Qu JY; Jiang H; Wang XF; Song XH; Hao CJ
Diagn Interv Radiol; 2022 Nov; 28(6):555-562. PubMed ID: 36550755
[TBL] [Abstract][Full Text] [Related]
7. Analysis of dual energy spectral CT and pathological grading of clear cell renal cell carcinoma (ccRCC).
Wei J; Zhao J; Zhang X; Wang D; Zhang W; Wang Z; Zhou J
PLoS One; 2018; 13(5):e0195699. PubMed ID: 29715308
[TBL] [Abstract][Full Text] [Related]
8. Differentiating intrapulmonary metastases from different primary tumors via quantitative dual-energy CT based iodine concentration and conventional CT attenuation.
Deniffel D; Sauter A; Dangelmaier J; Fingerle A; Rummeny EJ; Pfeiffer D
Eur J Radiol; 2019 Feb; 111():6-13. PubMed ID: 30691666
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Biexponential and Monoexponential Model of Diffusion-Weighted Imaging for Distinguishing between Common Renal Cell Carcinoma and Fat Poor Angiomyolipoma.
Ding Y; Zeng M; Rao S; Chen C; Fu C; Zhou J
Korean J Radiol; 2016; 17(6):853-863. PubMed ID: 27833401
[TBL] [Abstract][Full Text] [Related]
10. Normalized Dual-Energy Iodine Ratio Best Differentiates Renal Cell Carcinoma Subtypes Among Quantitative Imaging Biomarkers From Perfusion CT and Dual-Energy CT.
Manoharan D; Netaji A; Diwan K; Sharma S
AJR Am J Roentgenol; 2020 Dec; 215(6):1389-1397. PubMed ID: 33052738
[No Abstract] [Full Text] [Related]
11. Comparative study of conventional diffusion-weighted imaging and introvoxel incoherent motion in assessment of pathological grade of clear cell renal cell carcinoma.
Zhu Q; Zhu W; Wu J; Chen W; Ye J; Ling J
Br J Radiol; 2022 May; 95(1133):20210485. PubMed ID: 35442093
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment differentiation of renal cell carcinoma subtypes by CT: the influence of different tumor enhancement measurement approaches.
Zokalj I; Marotti M; Kolarić B
Int Urol Nephrol; 2014 Jun; 46(6):1089-100. PubMed ID: 24381132
[TBL] [Abstract][Full Text] [Related]
13. Dual-energy CT in differentiating benign sinonasal lesions from malignant ones: comparison with simulated single-energy CT, conventional MRI, and DWI.
Wang P; Tang Z; Xiao Z; Hong R; Wang R; Wang Y; Zhan Y
Eur Radiol; 2022 Feb; 32(2):1095-1105. PubMed ID: 34427744
[TBL] [Abstract][Full Text] [Related]
14. Value of CT spectral imaging in the differential diagnosis of thymoma and mediastinal lymphoma.
Xie Y; Zhang S; Liu J; Liang X; Zhang X; Zhang Y; Zhang Z; Zhou J
Br J Radiol; 2019 Mar; 92(1095):20180598. PubMed ID: 30507309
[TBL] [Abstract][Full Text] [Related]
15. Differentiating malignant and benign necrotic lung lesions using kVp-switching dual-energy spectral computed tomography.
Li Q; Fan X; Luo TY; Lv FJ; Huang XT
BMC Med Imaging; 2021 May; 21(1):81. PubMed ID: 33985454
[TBL] [Abstract][Full Text] [Related]
16. CT-based multi-phase Radiomic models for differentiating clear cell renal cell carcinoma.
Chen M; Yin F; Yu Y; Zhang H; Wen G
Cancer Imaging; 2021 Jun; 21(1):42. PubMed ID: 34162442
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis of chromophobe renal cell carcinoma and papillary renal cell carcinoma with dual-energy spectral computed tomography.
Wang D; Huang X; Bai L; Zhang X; Wei J; Zhou J
Acta Radiol; 2020 Nov; 61(11):1562-1569. PubMed ID: 32088966
[TBL] [Abstract][Full Text] [Related]
18. Can Spectral CT Imaging Improve the Differentiation between Malignant and Benign Solitary Pulmonary Nodules?
Zhang Y; Cheng J; Hua X; Yu M; Xu C; Zhang F; Xu J; Wu H
PLoS One; 2016; 11(2):e0147537. PubMed ID: 26840459
[TBL] [Abstract][Full Text] [Related]
19. Lesion Size and Iodine Quantification to Distinguish Low-Grade From High-Grade Clear Cell Renal Cell Carcinoma Using Dual-Energy Spectral Computed Tomography.
Zhao J; Zhang P; Chen X; Cao W; Ye Z
J Comput Assist Tomogr; 2016; 40(5):673-7. PubMed ID: 27224223
[TBL] [Abstract][Full Text] [Related]
20. Application of BOLD
Deng Y; Pan L; Xing W; Zhou Z; Chen J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):1010-1017. PubMed ID: 34707012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
